Lv3
386 积分 2024-10-14 加入
Economics and dementia: Challenges and responses
2天前
已完结
Galantamine-Memantine combination in the treatment of Alzheimer's disease and beyond
2天前
已完结
Alzheimer's disease
2天前
已完结
Tau biomarkers in Alzheimer's disease: towards implementation in clinical practice and trials
2天前
已完结
Comparative Efficacy and Safety of Monoclonal Antibodies for Cognitive Decline in Patients with Alzheimer’s Disease: A Systematic Review and Network Meta-Analysis
2天前
已完结
Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis
2天前
已完结
Monoclonal therapy with lecanemab in the treatment of mild Alzheimer's disease: A systematic review and meta-analysis
2天前
已完结
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease—Estimating the True Value
2天前
求助中
Cost-Effectiveness and Value-Based Pricing of Aducanumab for Patients With Early Alzheimer Disease
2天前
已完结
Cost-effectiveness comparison between blood biomarkers and conventional tests in Alzheimer's disease diagnosis
2天前
已完结
皖公网安备34019202002308
